Zeman P, Kasl J, Tupý R, Frei R, Kott O, Kautzner J
Klinika ortopedie a traumatologie pohybového ústrojí Lékařské fakulty Univerzity Karlovy a Fakultní nemocnice Plzeň.
Acta Chir Orthop Traumatol Cech. 2018;85(5):343-350.
PURPOSE OF THE STUDY The purpose of the prospective randomised study was to assess the benefits of the platelet-rich fibrin (PRF) application during the anatomic anterior cruciate ligament reconstruction (ACLR) for tendon graft healing. MATERIAL AND METHODS The study included 40 patients with an isolated rupture of the anterior cruciate ligament in the knee. The MRI findings on the tendon graft were evaluated at 6 months and 12 months after the surgery in a total of 33 patients, namely in 10 women/23 men (21 right knee/12 left knee), with the mean age of 29.1 years and at the mean follow-up of 15.9 weeks after the injury. The randomisation using envelopes was carried out at the beginning of arthroscopy either in the group with the PRF application (Group 1) (17 patients) or in the group without the PRF application (Group 2) (16 patients). The followed-up patients underwent the ACLR with targeting the femoral tunnel through anteromedial portal using the autografts of m. semitendinosusand m. graciliswith Tightrope femoral fixation and Inion implant in tibia. In Group 1, during the surgery PRF was applied both in the drilled tunnels (intraosseously) and directly to the surface of the tendon graft itself (intraarticular part). The Group 2 was a control group in which the same intervention was performed, however without the PRF application. In the 6 th and 12 th month after the surgery, the signal intensity of the knee and occurrence of the ACL graft failure, bone (marrow) oedema rate near the tunnels were assessed by an independent radiologist using a 3 Tesla MRI. RESULTS In the 6 th and also in the 12 th postoperative month, neither a complete, nor a partial graft failure was found in the group with PRF, whereas in Group 2 a complete or a partial graft failure was observed in 12.5% (p = 0.23). In the 6th month, a bone marrow oedema near the intraosseous parts of the graft was reported in 94.1% of patients in Group 1 and in 81.3% of patients in Group 2, while in the 12 th month it was 23.5% of evaluated patients in Group 1 and 37.5% patients in Group 2. The differences between the two groups were not statistically significant in the 6 th (p = 0.096) or in the 12 th month (p = 0.43). In the 6 th month, a fully ligamentised graft was found in 52.9% of patients in Group 1 and in 37.5% of patients in Group 2 (p = 0.061), a partially ligamentised graft was present in 47.1% of patients in Group 1 and in 50% of patients in Group 2. In the 12 th month, a fully ligamentised graft was seen in 94.1% of patients in Group 1 and in 75% of patients in Group 2 (p = 0.26) and a partially ligamentised graft was present in 5.9% of patients in Group 1 and in 12.5% of patients in Group 2. In the remaining 12.5% of patients in Group 2, the finding was assessed as a graft with no signs of ligamentisation. DISCUSSION We have not encountered a paper in the Czech or world literature which would present results of a similar study, i.e. which would evaluate the potential benefits of the platelet-rich fibrin application in the course of the anatomic anterior cruciate ligament reconstruction. Majority of studies evaluate the benefits of the application of platelet-rich plasma aimed to achieve a positive effect on the LCA graft healing. CONCLUSIONS Our study proved a higher percentage of ligamentisation and healed grafts into the bone as well as a lower occurrence of graft failure in the group with PRF compared to the group without the PRF application, namely both in the 6 th and in the 12 th month. Nonetheless, the differences between the two groups assessed at the same time were not statistically significant. Key words: anterior cruciate ligament, arthroscopy, anatomic ACL reconstruction, magnetic resonance imaging of the graft, platelet-rich fibrin, graft healing, MRI signal intensity of the graft.
研究目的 这项前瞻性随机研究的目的是评估在解剖学前交叉韧带重建(ACLR)过程中应用富血小板纤维蛋白(PRF)对肌腱移植物愈合的益处。材料与方法 该研究纳入了40例膝关节单纯前交叉韧带断裂的患者。对总共33例患者(10名女性/23名男性,21例右膝/12例左膝)在术后6个月和12个月时对肌腱移植物的MRI结果进行评估,平均年龄为29.1岁,受伤后平均随访15.9周。在关节镜检查开始时,使用信封法进行随机分组,分为应用PRF的组(第1组)(17例患者)和未应用PRF的组(第2组)(16例患者)。随访患者通过前内侧入路以半腱肌和股薄肌自体移植物进行ACLR,采用Tightrope股骨固定和Inion胫骨植入物。在第1组中,手术过程中PRF既应用于钻孔隧道内(骨内),也直接应用于肌腱移植物本身的表面(关节内部分)。第2组为对照组,进行相同的干预,但不应用PRF。术后第6个月和第12个月,由一名独立放射科医生使用3特斯拉MRI评估膝关节的信号强度、ACL移植物失败的发生情况以及隧道附近骨(骨髓)水肿率。结果 在术后第6个月和第12个月,应用PRF的组中均未发现完全或部分移植物失败,而在第2组中观察到12.5%的完全或部分移植物失败(p = 0.23)。在第6个月,第1组94.1%的患者和第2组81.3%的患者报告移植物骨内部分附近有骨髓水肿,而在第12个月,第1组评估患者中有23.5%出现骨髓水肿,第2组为37.5%。两组之间在第6个月(p = 0.096)或第12个月(p = 0.43)的差异无统计学意义。在第6个月,第1组52.9%的患者和第2组37.5%的患者发现移植物完全韧带化(p = 0.061),第1组47.1%的患者和第2组50%的患者存在部分韧带化移植物。在第12个月,第1组94.1%的患者和第2组75%的患者可见移植物完全韧带化(p = 0.26),第1组5.9%的患者和第2组12.5%的患者存在部分韧带化移植物。在第2组其余12.5%的患者中,该发现被评估为无韧带化迹象的移植物。讨论 在捷克或世界文献中,我们尚未遇到一篇展示类似研究结果的论文,即评估在解剖学前交叉韧带重建过程中应用富血小板纤维蛋白的潜在益处的论文。大多数研究评估了应用富血小板血浆的益处,旨在对LCA移植物愈合产生积极影响。结论 我们的研究证明,与未应用PRF的组相比,应用PRF的组在第6个月和第12个月时韧带化和移植物与骨愈合的比例更高,移植物失败的发生率更低。尽管如此,两组在同一时间评估的差异无统计学意义。关键词:前交叉韧带;关节镜检查;解剖学ACL重建;移植物的磁共振成像;富血小板纤维蛋白;移植物愈合;移植物的MRI信号强度